Insider · CIK 0001702957

Schwartz Jeffrey Lawrence

Reports to the SEC for 10 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001702957

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-09	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Director, 10% Owner	AAward	+7,217 sh	—	—	14,236
2026-09-08	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.S Sale	Director, 10% Owner	SSale	−3,890 sh	$25.18	−$97.9K	7,019
2025-09-04	KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.A Award	Director, 10% Owner	AAward	+10.9K sh	—	—	10,909
2024-05-23	RPIDRAPID MICRO BIOSYSTEMS, INC.A Award	Director, 10% Owner	AAward	+14.3K sh	—	—	14,300
2024-05-23	RPIDRAPID MICRO BIOSYSTEMS, INC. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+28.7K sh	—	—	28,650
2023-05-24	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,774
2023-05-24	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,648 sh	—	—	10,572
2023-05-04	RPIDRAPID MICRO BIOSYSTEMS, INC. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+25K sh	—	—	25,000
2023-03-16	SpringWorks Therapeutics, Inc.S Sale	Director	SSale	−1.75M sh	$28.50	−$49.9M	3,081,307
2022-05-23	RPIDRAPID MICRO BIOSYSTEMS, INC. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+12.5K sh	—	—	12,500
2022-05-19	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+4,818 sh	—	—	5,924
2022-05-19	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.3K sh	—	—	15,318
2021-07-14	RPIDRAPID MICRO BIOSYSTEMS, INC. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+25K sh	—	—	25,000
2021-05-20	SpringWorks Therapeutics, Inc.A Award	Director	AAward	+1,106 sh	—	—	1,106
2021-05-20	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,998 sh	—	—	6,998
2020-10-26	BCLS Acquisition Corp.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+488K sh	$10.00	+$4.88M	487,500
2020-05-20	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+7,464 sh	—	—	7,464
2019-09-12	SpringWorks Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	29,983
2019-03-29	SpringWorks Therapeutics, Inc.Series A Convertible Preferred StockA Award	Director	AAward	+40M sh	—	—	6,078,103
2019-03-29	SpringWorks Therapeutics, Inc.Series B Convertible Preferred StockA Award	Director	AAward	+6.93M sh	—	—	1,053,204

Recent filings

Accepted (ET)
Sep 104
Schwartz Jeffrey Lawrence0000950130-26-000223
SEC(opens sec.gov)
Sep 84
Schwartz Jeffrey Lawrence0000950170-25-113627
SEC(opens sec.gov)
May 284
Schwartz Jeffrey Lawrence0000950170-24-065323
SEC(opens sec.gov)
May 254
Schwartz Jeffrey Lawrence0000899243-23-013903
SEC(opens sec.gov)
May 54
Schwartz Jeffrey Lawrence0000899243-23-012409
SEC(opens sec.gov)
Mar 204
Schwartz Jeffrey Lawrence0000899243-23-009117
SEC(opens sec.gov)
Jun 104
Schwartz Jeffrey Lawrence0000899243-22-022034
SEC(opens sec.gov)
May 204
Schwartz Jeffrey Lawrence0000899243-22-019105
SEC(opens sec.gov)
Jul 164
Schwartz Jeffrey Lawrence0000899243-21-028644
SEC(opens sec.gov)
May 244
Schwartz Jeffrey Lawrence0000899243-21-020446
SEC(opens sec.gov)
Oct 264
Schwartz Jeffrey Lawrence0000899243-20-029239
SEC(opens sec.gov)
May 224
Schwartz Jeffrey Lawrence0000899243-20-013997
SEC(opens sec.gov)
Sep 164
Schwartz Jeffrey Lawrence0000899243-19-023677
SEC(opens sec.gov)

Companies

Address

C/O BAIN CAPITAL INVESTORS, LLC 200 CLARENDON STREET

BOSTON, MA, 02116